SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,132.81 -382.62
( -0.50%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-11.5421201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

200.38

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	112.98	109.30	39.64	30.99	60.52	52.03
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	112.98	109.30	39.64	30.99	60.52	52.03
Other Income	0.29	1.31	0.10	0.14	1.36	2.28
Stock Adjustments	8.20	3.76	1.53	4.63	-4.55	6.39
Total Income	121.47	114.37	41.27	35.76	57.33	60.70
EXPENDITURE :
Raw Materials	110.34	100.23	35.06	28.64	42.67	43.02
Power & Fuel Cost	6.83	6.37	4.15	4.16	3.04	2.79
Employee Cost	7.61	6.76	5.96	5.74	0.58	4.08
Other Manufacturing Expenses	8.58	5.97	3.28	2.43	6.31	2.88
Selling & Administrative Expenses	2.49	2.56	2.39	1.75	1.88	1.79
Miscellaneous Expenses	0.65	0.99	0.04	0.87	0.82	0.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	136.51	122.87	50.89	43.59	55.31	54.57
Operating Profit	-15.04	-8.51	-9.62	-7.83	2.02	6.12
Interest	4.82	2.23	1.59	1.49	0.92	1.78
Gross Profit	-19.86	-10.74	-11.21	-9.32	1.10	4.34
Depreciation	2.32	3.61	2.66	2.05	1.59	1.20
Profit Before Tax	-22.18	-14.35	-13.87	-11.37	-0.49	3.14
Tax	0.00	0.16	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-4.61	-4.21	-10.39	0.20	0.12	0.21
Reported Net Profit	-17.57	-10.30	-3.48	-11.57	-0.61	2.93
Extraordinary Items	0.00	0.05	0.04	-0.72	0.43	2.04
Adjusted Net Profit	-17.57	-10.35	-3.52	-10.85	-1.04	0.89
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-74.18	-63.88	-60.40	-48.83	-48.22	-51.15
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-91.75	-74.18	-63.88	-60.40	-48.83	-48.22
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-4.75	-2.78	-1.04	-8.15	-0.43	2.87
Earnings Per Share(Adj)-Unit Curr	-4.75	-2.78	-1.04	-8.15	-0.43	2.87
Book Value-Unit Curr	-11.54	-6.93	-6.18	-32.53	-24.38	-37.27
Book Value(Adj)-Unit Curr	-11.54	-6.93	-6.18	-32.53	-24.38	-37.27

76,132.81 -382.62 ( -0.50%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

66,225.50 1,204.56 (1.85%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)